Epidemiology of Invasive Haemophilus influenzae Disease, Europe, 2007–2014

We describe the epidemiology of invasive Haemophilus influenzae disease during 2007–2014 in 12 European countries and assess overall H. influenzae disease trends by serotype and patient age. Mean annual notification rate was 0.6 cases/100,000 population, with an increasing annual trend of 3.3% (95% CI 2.3% to 4.3%). The notification rate was highest for patients <1 month of age (23.4 cases/100,000 population). Nontypeable H. influenzae (NTHi) caused 78% of all cases and showed increasing trends among persons <1 month and >20 years of age. Serotype f cases showed an increasing trend among persons >60 years of age. Serotype b cases showed decreasing trends among persons 1–5 months, 1–4 years, and >40 years of age. Sustained success of routine H. influenzae serotype b vaccination is evident. Surveillance systems must adopt a broad focus for invasive H. influenzae disease. Increasing reports of NTHi, particularly among neonates, highlight the potential benefit of a vaccine against NTHi.

[1]  S. Ladhani,et al.  Clinical and Molecular Epidemiology of Childhood Invasive Nontypeable Haemophilus influenzae Disease in England and Wales , 2016, The Pediatric infectious disease journal.

[2]  G. Tyrrell,et al.  Laboratory characterization of invasive Haemophilus influenzae isolates from Nunavut, Canada, 2000–2012 , 2016, International journal of circumpolar health.

[3]  L. Ravà,et al.  Carriage of Haemophilus influenzae in the oropharynx of young children and molecular epidemiology of the isolates after fifteen years of H. influenzae type b vaccination in Italy. , 2015, Vaccine.

[4]  Samir N. Patel,et al.  The Epidemiology of Invasive Haemophilus influenzae Non-Serotype B Disease in Ontario, Canada from 2004 to 2013 , 2015, PloS one.

[5]  M. Cerquetti,et al.  Neonatal Invasive Haemophilus influenzae Disease and Genotypic Characterization of the Associated Strains in Italy. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  T. Murphy.  Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now , 2015, Clinical and Vaccine Immunology.

[7]  S. Ladhani,et al.  Neonatal invasive Haemophilus influenzae disease in England and Wales: epidemiology, clinical characteristics, and outcome. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  S. Ladhani,et al.  Non-typeable Haemophilus influenzae, an under-recognised pathogen. , 2014, The Lancet. Infectious diseases.

[9]  F. Tubau,et al.  Clinical and Molecular Epidemiology of Haemophilus influenzae Causing Invasive Disease in Adult Patients , 2014, PloS one.

[10]  S. Ladhani,et al.  Risk of invasive Haemophilus influenzae infection during pregnancy and association with adverse fetal outcomes. , 2014, JAMA.

[11]  S. Ladhani,et al.  Invasive Haemophilus influenzae type b disease in England and Wales: who is at risk after 2 decades of routine childhood vaccination? , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  R. Sá-Leão,et al.  Characteristics of Haemophilus influenzae invasive isolates from Portugal following routine childhood vaccination against H. influenzae serotype b (2002–2010) , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[13]  M. Ulanova.  Global Epidemiology of Invasive Haemophilus influenzae Type a Disease: Do We Need a New Vaccine? , 2013 .

[14]  D. Levy-bruhl,et al.  Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction , 2013, Epidemiology and Infection.

[15]  W. Schaffner,et al.  Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes. , 2012, The Journal of infection.

[16]  H. Erlendsdóttir,et al.  Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  S. Ladhani,et al.  Invasive Haemophilus influenzae Serotype e and f Disease, England and Wales , 2012, Emerging infectious diseases.

[18]  M. Ulanova,et al.  Risk of Invasive Haemophilus influenzae Type b (Hib) Disease in Adults with Secondary Immunodeficiency in the Post-Hib Vaccine Era , 2012, Clinical and Vaccine Immunology.

[19]  S. Madhi,et al.  Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009. , 2012, Vaccine.

[20]  Raydel D. Mair,et al.  Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  J. Gilsdorf,et al.  Invasive disease caused by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strains. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[22]  Saheli Sadanand.  Harrison’s Infectious Diseases , 2011, The Yale Journal of Biology and Medicine.

[23]  R. Veenhoven,et al.  Nontypeable Haemophilus influenzae invasive disease in The Netherlands: a retrospective surveillance study 2001-2008. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  M. Caporali,et al.  Ten years of Hib vaccination in Italy: prevalence of non-encapsulated Haemophilus influenzae among invasive isolates and the possible impact on antibiotic resistance. , 2011, Vaccine.

[25]  S. Ladhani,et al.  Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[26]  D. Fisman,et al.  Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. , 2010, Vaccine.

[27]  M. Gubina,et al.  Characterisation of invasive Haemophilus influenzae isolates in Slovenia, 1993–2008 , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[28]  S. Ladhani,et al.  Invasive Haemophilus influenzae Disease, Europe, 1996–2006 , 2010, Emerging infectious diseases.

[29]  R. von Kries,et al.  Invasive Haemophilus influenzae infections in Germany: impact of non-type b serotypes in the post-vaccine era , 2009, BMC infectious diseases.

[30]  J. Rosenbauer,et al.  Surveillance for rare infectious diseases: is one passive data source enough for Haemophilus influenzae? , 2008, European journal of public health.

[31]  S. Ladhani,et al.  No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccine. , 2008, The Lancet. Infectious diseases.

[32]  P. Kriz,et al.  Large decrease in incidence of invasive Haemophilus influenzae b disease following introduction of routine vaccination in the Czech Republic. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[33]  D. Kelly,et al.  Haemophilus influenzae type b conjugate vaccines , 2004, Immunology.

[34]  H. Peltola.  Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. , 2000, Clinical microbiology reviews.

[35]  E. Moxon,et al.  Population-based study of non-typable Haemophilus influenzae invasive disease in children and neonates , 1993, The Lancet.

[36]  C. Wilfert.  Epidemiology of Haemophilus influenzae type b infections. , 1990, Pediatrics.

[37]  B. Claesson,et al.  Incidence, predisposing factors and manifestations of invasiveHaemophilus influenzae infections in adults , 1984, European Journal of Clinical Microbiology.

[38]  R. Evans.  European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[39]  L. Harrison,et al.  Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.

[40]  D. Crook,et al.  The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. , 1995, The Journal of infectious diseases.